Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. - Wikidata - awgldk - TriplyDB

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

http://www.wikidata.org/entity/Q35112115

about

An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling 3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs RNA interference and potential therapeutic applications of short interfering RNAs Anti-neoplastic efficacy of Haimiding on gastric carcinoma and its mechanisms Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells.Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis.Miniature Dielectric Barrier Discharge Nonthermal Plasma Induces Apoptosis in Lung Cancer Cells and Inhibits Cell Migration Selective cytotoxicity of Ponciri Fructus against glucose-deprived PANC-1 human pancreatic cancer cells via blocking activation of GRP78.RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy.Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin Down-regulation of telomerase activity and activation of caspase-3 are responsible for Tanshinone I-induced apoptosis in monocyte leukemia cells in vitro TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases.Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analogues Comparison of caspase-3 activation in tumor cells upon treatment of chemotherapeutic drugs using capillary electrophoresis.CaMKII Inhibitor KN-62 Blunts Tumor Response to Hypoxia by Inhibiting HIF-1α in Hepatoma Cells.Tumor xenograft uptake of a pyrrole-imidazole (Py-Im) polyamide varies as a function of cell line grafted.Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning.Free radical theory of autoimmunity Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.Nuclear proteomics with XRCC3 knockdown to reveal the development of doxorubicin-resistant uterine cancer.Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.Hybridized doxorubicin-Au nanospheres exhibit enhanced near-infrared surface plasmon absorption for photothermal therapy applications.Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells.Schisandrin B inhibits the proliferation of human lung adenocarcinoma A549 cells by inducing cycle arrest and apoptosis.Drug resistance in glioblastoma: a mini review Selective inhibition of EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent anti-tumor activity in breast cancer.Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter Proteomic approaches for studying chemoresistance in cancer.Targeting the cancer cell cycle by cold atmospheric plasma The therapeutic potential of RNA interference.Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay Broad targeting of resistance to apoptosis in cancer.Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells.REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer.Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.

P2860

Q21245772-8938C40C-D841-4011-BC82-EF66390E0C2B Q24296238-999EAABC-A6B4-429B-8055-967E515B233B Q24337691-B4C3FE2E-9179-4F61-9C53-26AFE1E213BB Q26766039-CABA356F-83F5-43B3-A2C3-CE266EDECFBC Q28250480-BBEC1204-461F-4048-98CE-B7B1244F65F1 Q33198297-7F89FB65-947D-4ADD-8E99-F8A8967B891E Q33226642-CEBEC93C-BB1E-4D17-B03A-A04188AE6632 Q33423866-E94550DB-A8B8-480F-AFC6-7DC6324671C0 Q33469924-9FC6CFEC-98ED-4850-BB2D-F6705344C3B0 Q33508992-AACB674C-B3CD-4D9F-BA6F-F6DAF4C029D1 Q33805534-E8476871-35A8-4C80-92CA-00EB133D8E24 Q33947942-1F9560FA-FFE1-4607-8008-7E5380EA903E Q33998780-21EA9BDC-B53C-4326-8E40-00137EEAD905 Q34053698-896FF97E-34D8-4AB0-9A95-A9C26C1ACDBC Q34153747-69C292A3-D2A9-40ED-B8C4-D22CB324A351 Q34243306-805E57BF-B1BA-407D-B6FD-429D5635FD9F Q34382055-E34BD3D1-F427-4005-A9B0-C9A00D3D7665 Q34394131-1A48501A-5A50-41AB-9F08-512A59D10FD2 Q34460758-C26655B7-154E-4D1A-91EA-52D0E84E7622 Q34610733-1D233810-4440-48D7-A717-15FE10D8A184 Q34786280-D780205D-414E-4D97-8065-C44CCC333EAB Q35032548-4AB9FA39-888B-412A-8980-088050626766 Q35106014-72BAF548-FFB6-4765-8768-9FE2E149F92F Q35133116-AFBABC5E-F582-4AFC-830D-4F3438ADCFB0 Q35136562-3934671F-52AF-4FF3-ABDA-2F455205B637 Q35574749-9346DF8E-7A8E-4858-AF16-E6E969504480 Q35578037-E65F5EBD-F6EB-4BD7-82DA-789B50B0A445 Q35759931-18FF4F10-C2BF-481F-99CB-F953AAC79BC8 Q35870634-751E3392-266C-422B-B44C-68537A593842 Q35899534-E3BE90CA-7888-4A65-8028-C883242DC329 Q35921549-E03213F8-A43C-407F-B6BA-EA3011F6B671 Q36021057-41B31AC9-4E01-4E47-9A85-C06741B0DF69 Q36126469-3FF14EC1-CE63-404B-BCF3-484945F3883B Q36210563-EFB0DDB0-2E39-4DFA-86A2-7ABAEDE49D16 Q36237868-A3C2FC0E-FC3C-47E4-B36B-6835B118F50D Q36270038-A2881F2D-4A7C-4842-97A3-4859276E60E7 Q36483749-0F04035A-7261-4FF4-BE7D-9C2ACC182E1D Q36591295-263BA2A5-7821-448B-8BD7-D4F18DC87F6C Q36594051-4B4929A5-8293-4BCE-8893-3036884CBF2D Q36741693-208C92CE-B389-478A-A8B1-0495FE85422C

P2860

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

http://www.wikidata.org/entity/Q35112115

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

@ast

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

@en

type

label

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

@ast

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

@en

prefLabel

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

@ast

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

@en

P1433

Q35112115-C0210BF1-2E3D-4ED5-8E3F-9EC16CF1999C

P1476

Q35112115-FDA17722-0BBD-46B3-9CF6-9DAD1546BD98

P2093

Q35112115-0DFD91AC-6786-4234-94C4-C2AFCBD7C699

Q35112115-1A6725E1-3610-421F-8179-1BA9863FCA0C

Q35112115-410DCB82-B0C6-411B-A081-4C0D6EC5E5FA

Q35112115-5B4E9904-07F7-48D0-BC58-21A27F63A84F

Q35112115-5F5C6BBF-92BD-4F40-BDFF-24813CF51398

Q35112115-AA9FC758-868D-46BD-8EC7-88B57F0E7798

Q35112115-F6442970-D95B-4C98-AE61-C890B6E32E09

P2860

Q35112115-09C3582F-3AA2-40E0-B189-8B6DD4DAD623

Q35112115-1446773D-1ADD-413D-A189-817BC16DE93C

Q35112115-1B688A56-3893-48AE-B2CB-00BA2E7EE8C6

Q35112115-1BE16C03-28B9-421A-A17D-2E6747EFE797

Q35112115-2715B52D-9A22-421E-8D13-AEB2DD9960B5

Q35112115-31342A04-4791-4C3B-A2E3-EC01044C1DAE

Q35112115-352D559A-CA61-4A93-8100-7B5065A615EB

Q35112115-3601DA47-9041-45BC-BDE6-5ACE010A8F40

Q35112115-5555E1AF-A50F-45E6-B81F-C38E268B3315

Q35112115-63E1B942-05DF-44D7-87FA-025DB0380BE2

P304

Q35112115-36F9D061-E664-45B8-9374-BD66A195B6A5

P31

Q35112115-7B22AC68-CAB4-4BDE-97E9-9D7CB59D1AE4

P356

Q35112115-F09E7C37-C726-48E8-A6E7-99A10300C1C9

P433

Q35112115-64DC7037-DDAE-42CD-A495-39E7D6611AB0

P478

Q35112115-67609B91-88AD-43F9-834D-78028710ECC7

P577

Q35112115-57FC07F5-2C30-4B6E-B696-C3EDB145E2FC

P5875

Q35112115-FCC29555-4A57-487D-B7FA-7417502D5658

P698

Q35112115-43318283-C5A6-4FF2-87FC-D34A44F4308A

P356

J.1349-7006.2003.TB01345.X

P1433

P1476

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

@en

P2093

Akihiro Tomida

http://www.w3.org/2001/XMLSchema#string

Hiroshi Sakamoto

http://www.w3.org/2001/XMLSchema#string

Mikihiko Naito

http://www.w3.org/2001/XMLSchema#string

Naomi Haga

http://www.w3.org/2001/XMLSchema#string

Naoya Fujita

http://www.w3.org/2001/XMLSchema#string

Takashi Tsuruo

http://www.w3.org/2001/XMLSchema#string

Tetsuo Mashima

http://www.w3.org/2001/XMLSchema#string

P2860

The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life

The PI3K-PDK1 connection: more than just a road to PKB

Modulation of Akt kinase activity by binding to Hsp90

Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization

Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release

Induction of apoptosis by cancer chemotherapy.

Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE

Proteasome inhibition: a novel approach to cancer therapy.

The unfolded protein response in nutrient sensing and differentiation.

Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2.

P304

15-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2003.TB01345.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10793920

http://www.w3.org/2001/XMLSchema#string

P698

12708468

http://www.w3.org/2001/XMLSchema#string